Ramesh Venkataraman: "Renal Replacement Therapy for AKI"
Release Date: 12/19/2021
Liz Crowe: "Is it Moral to Feel Moral Distress?"
Critical Care Medicine
Upon completion of this activity, you should be able to:
info_outline
Professor Andrew Udy: "Brain Monitoring in Traumatic Brain Injury"
Critical Care Medicine
Upon completion of this activity, you should be able to:
info_outline
Professor Michael O'Leary: "Organ Donation"
Critical Care Medicine
After completing this lecture you will be able to:
info_outline
Professor Greg Hare: "Patient Blood Management and Treatment of Anemia in Critical Care"
Critical Care Medicine
Coming soon
info_outline
Ramesh Venkataraman: "Renal Replacement Therapy for AKI"
Critical Care Medicine
After watching the lecture you should be able to:
info_outline
Professor Kathryn Maitland: "Management of Gastroenteritis in Resource Limited Settings"
Critical Care Medicine
At the end of this lecture, you should be able to:
info_outline
Federico Angriman: "Non-Invasive Oxygenation Strategies"
Critical Care Medicine
On completion of this lecture, you will be able to:
info_outline
Tim Baker: "Essential Emergency & Critical Care"
Critical Care Medicine
Upon completion of this activity, you should be able to:
info_outline
Professor Charles Sprung: "Foregoing Life-Sustaining Treatment in the ICU"
Critical Care Medicine
Upon completion of this activity, you should be able to:
info_outline
Paul Young: "Potential Solutions to the Problems of Clinical Trial Science"
Critical Care Medicine
On completion of this activity you should be able to:
info_outlineAcute Kidney Injury (AKI) affects nearly 40% of intensive care unit (ICU) patients and carries significant morbidity and mortality. Once AKI is established, renal replacement therapy (RRT) is the mainstay of supportive care. The best time to initiate RRT is still unclear. Although several studies have evaluated early vs. late RRT in AKI, there is no clear consensus on how “early” or “late” should be defined. Existing evidence does not support the initiation of RRT based on any particular stage of AKI. Risk-benefit of RRT along with the host's ability to tolerate homeostatic derangements should be taken into account prior to initiating RRT. Continuous RRT (CRRT) has not been shown to be superior to intermittent hemodialysis (IHD). A CRRT dose of at least 20ml/kg/hour or an IHD dose of Kt/V 1.2 thrice a week seems to be adequate for patients with AKI in the ICU. Improvement of urine output and trend in azotemia can serve as a guide in weaning and termination of RRT. Diuretics have not been shown to decrease the need or frequency of RRT.